Azmi Nabulsi - 16 May 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: Chief Operating Officer
Signature: /s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol: PHAT
Transactions as of: 16 May 2022
Transactions value $: $163,288
Form type: 4
Filing time: 16 May 2022, 20:48:00 UTC
Previous filing: 21 Jan 2022
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Purchase	$163K	+20K	+2.61%	$8.16	786K	16 May 2022	by Trust	F1
holding	PHAT	Common Stock						21.4K	16 May 2022	Direct
holding	PHAT	Common Stock						843	16 May 2022	by 401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.